Reported positions
Quarter-end holdings as filed
Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.
ARMISTICE CAPITAL, LLC
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ · methodology §13F ↗
Period
$5.6B
reported valuesum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
267
positionsALL retained default holdings for this (filer, period), including NULL-value ones
105
new stakespositions with no comparable holding in the prior quarter (kind new), 2026-03-31
208
exitspositions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
Position changes — into 2026-03-31
by shares · Δ value · filing link · how changes are classified §Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
STATE STR SPDR S&P 500 ETF T TR UNITposition key pos:12423 · issuer key iss:1897 PUT | trim | −$680M | −900,000 | $2.0B | $1.4B | 3,000,000 | 2,100,000 | |
ISHARES TR RUSSELL 2000 ETFposition key pos:16595 · issuer key iss:1231 PUT | trim | −$1.1B | −4,600,000 | $2.0B | $868M | 8,100,000 | 3,500,000 | |
TRAVERE THERAPEUTICS INC COMposition key pos:18617 · issuer key iss:2158 | add | +$1.7M | +1,133,526 | $144M | $146M | 3,763,891 | 4,897,417 | |
PTC THERAPEUTICS INC COMposition key pos:18526 · issuer key iss:1662 | trim | −$71.5M | −727,420 | $213M | $141M | 2,801,869 | 2,074,449 | |
MADRIGAL PHARMACEUTICALS INC COMposition key pos:15238 · issuer key iss:1407 | trim | −$16.2M | −1,122 | $155M | $139M | 265,705 | 264,583 | |
CYTOKINETICS INC COM NEWposition key pos:13331 · issuer key iss:700 CALL | add | +$16.7M | +200,000 | $95.3M | $112M | 1,500,000 | 1,700,000 | |
AGIOS PHARMACEUTICALS INC COMposition key pos:14037 · issuer key cusip6:00847X CALL | add | +$26.6M | +200,000 | $81.7M | $108M | 3,000,000 | 3,200,000 | |
SUPERNUS PHARMACEUTICALS COMposition key sid:sec:prov:38b7ce53f517b4f397d48b58dc3386d9 · issuer key cusip6:868459 | trim | −$39.4M | −868,653 | $137M | $98.0M | 2,764,000 | 1,895,347 | |
NEUROCRINE BIOSCIENCES INC COMposition key pos:12315 · issuer key iss:1552 | trim | −$21.0M | −96,240 | $116M | $95.4M | 820,240 | 724,000 | |
AGIOS PHARMACEUTICALS INC COMposition key pos:14037 · issuer key cusip6:00847X | trim | +$9.2M | −320,000 | $82.6M | $91.9M | 3,036,000 | 2,716,000 | |
IMMUNOVANT INC COMposition key sid:sec:prov:c0680e314bfe2d1131f5c3d642c67920 · issuer key cusip6:45258J | trim | −$57.5M | −2,182,239 | $146M | $88.6M | 5,747,155 | 3,564,916 | |
FRESHPET INC COMposition key pos:11169 · issuer key iss:964 | trim | −$14.5M | −202,693 | $79.0M | $64.5M | 1,296,000 | 1,093,307 | |
INCYTE CORP COMposition key pos:16771 · issuer key iss:1169 | trim | −$46.6M | −441,285 | $108M | $61.8M | 1,098,102 | 656,817 | |
DYNE THERAPEUTICS INC COMposition key pos:14578 · issuer key iss:778 | trim | −$6.0M | −74,598 | $63.6M | $57.6M | 3,249,708 | 3,175,110 | |
AMAZON COM INC COMposition key pos:15054 · issuer key iss:159 | trim | −$30.3M | −105,496 | $84.9M | $54.6M | 367,633 | 262,137 | |
IRONWOOD PHARMACEUTICALS INC COM CL Aposition key pos:14244 · issuer key iss:1229 | trim | −$1.3M | −997,000 | $54.0M | $52.7M | 16,025,000 | 15,028,000 | |
CYTOKINETICS INC COM NEWposition key pos:13331 · issuer key iss:700 | trim | −$12.7M | −228,228 | $63.1M | $50.4M | 992,766 | 764,538 | |
IMMUNOVANT INC COMposition key sid:sec:prov:c0680e314bfe2d1131f5c3d642c67920 · issuer key cusip6:45258J CALL | add | +$28.1M | +1,150,000 | $19.1M | $47.2M | 750,000 | 1,900,000 | |
HARMONY BIOSCIENCES HLDGS IN COMposition key pos:14335 · issuer key iss:1083 | add | +$26.8M | +1,124,000 | $18.7M | $45.5M | 500,000 | 1,624,000 | |
THERMO FISHER SCIENTIFIC INC COMposition key pos:16012 · issuer key iss:2132 | add | +$8.6M | +28,653 | $36.4M | $45.0M | 62,838 | 91,491 | |
NEKTAR THERAPEUTICS COM NEWposition key sid:sec:prov:8689270ade82a464b05b5b23e79f9006 · issuer key cusip6:640268 | trim | +$16.4M | −18,000 | $25.2M | $41.6M | 596,000 | 578,000 | |
UNITEDHEALTH GROUP INC COMposition key pos:17013 · issuer key iss:2218 | new | +$40.0M | +148,000 | $0 | $40.0M | — | 148,000 | |
UBER TECHNOLOGIES INC COMposition key pos:13563 · issuer key iss:2188 | add | +$14.2M | +236,026 | $23.1M | $37.3M | 282,734 | 518,760 | |
IMMUNOCORE HLDGS PLC ADSposition key pos:16434 · issuer key iss:1166 | add | −$2.3M | +90,000 | $38.1M | $35.8M | 1,098,000 | 1,188,000 | |
DENTSPLY SIRONA INC COMposition key pos:12615 · issuer key iss:723 | trim | −$48.6M | −4,298,000 | $83.4M | $34.8M | 7,298,000 | 3,000,000 | |
RIGEL PHARMACEUTICALS INC COMposition key sid:sec:prov:fd7b61c158906c86402255a51c19f819 · issuer key cusip6:766559 | add | −$1.2M | +444,000 | $35.8M | $34.6M | 836,000 | 1,280,000 | |
DISC MEDICINE INC COMposition key pos:13022 · issuer key iss:741 | add | −$5.4M | +36,609 | $39.7M | $34.3M | 499,391 | 536,000 | |
ALPHABET INC CAP STK CL Aposition key pos:16029 · issuer key iss:152 | trim | −$27.4M | −77,906 | $61.5M | $34.1M | 196,420 | 118,514 | |
MINERALYS THERAPEUTICS INC COMposition key sid:sec:prov:d00159df48fd34cc806ae902a076ba0a · issuer key cusip6:603170 | add | +$7.3M | +499,965 | $24.5M | $31.9M | 676,035 | 1,176,000 | |
HUBSPOT INC COMposition key pos:15184 · issuer key iss:1134 | add | +$4.1M | +60,583 | $27.3M | $31.4M | 68,000 | 128,583 | |
ORTHOFIX MED INC COMposition key sid:sec:prov:2dd39154b043cf25ad12f54df878e5cb · issuer key cusip6:68752M | add | −$9.2M | +52,000 | $40.1M | $31.0M | 2,648,000 | 2,700,000 | |
KURA ONCOLOGY INC COMposition key sid:sec:prov:44dcd89ab4e3fa904b2bfbfadeb83d25 · issuer key cusip6:50127T | trim | −$20.9M | −1,200,000 | $51.3M | $30.4M | 4,936,000 | 3,736,000 | |
AVANOS MED INC COMposition key pos:11587 · issuer key iss:283 | trim | −$7.9M | −1,200,000 | $35.9M | $28.0M | 3,200,000 | 2,000,000 | |
REGENERON PHARMACEUTICALS COMposition key pos:16027 · issuer key iss:1826 | trim | −$36.9M | −47,874 | $64.8M | $27.9M | 84,000 | 36,126 | |
ALIGN TECHNOLOGY INC COMposition key pos:14931 · issuer key iss:134 | add | +$15.2M | +81,855 | $11.9M | $27.1M | 76,104 | 157,959 | |
PTC THERAPEUTICS INC COMposition key pos:18526 · issuer key iss:1662 CALL | new | +$26.6M | +390,000 | $0 | $26.6M | — | 390,000 | |
MONGODB INC CL Aposition key pos:16631 · issuer key iss:1497 | add | +$5.6M | +58,152 | $20.6M | $26.3M | 49,144 | 107,296 | |
ALIBABA GROUP HLDG LTD SPONSORED ADSposition key pos:16587 · issuer key iss:133 | trim | −$21.2M | −115,100 | $46.8M | $25.6M | 319,100 | 204,000 | |
MEDLINE INC COM CL Aposition key pos:16301 · issuer key iss:1457 | add | +$22.7M | +506,841 | $2.4M | $25.1M | 58,016 | 564,857 | |
KALVISTA PHARMACEUTICALS INC COMposition key pos:10966 · issuer key cusip6:483497 | add | +$12.0M | +436,000 | $12.9M | $24.9M | 800,000 | 1,236,000 | |
DATADOG INC CL A COMposition key pos:17430 · issuer key iss:713 | trim | −$8.6M | −35,973 | $33.3M | $24.6M | 244,537 | 208,564 | |
HUMANA INC COMposition key pos:11393 · issuer key iss:1136 | add | +$6.1M | +69,582 | $18.4M | $24.5M | 71,697 | 141,279 | |
SENTINELONE INC CL Aposition key pos:12386 · issuer key iss:1955 | trim | −$11.9M | −524,370 | $36.3M | $24.4M | 2,422,219 | 1,897,849 | |
VERASTEM INC COM NEWposition key pos:14035 · issuer key cusip6:92337C | add | −$3.0M | +1,056,000 | $27.3M | $24.3M | 3,536,000 | 4,592,000 | |
FIVE9 INC COMposition key pos:10974 · issuer key iss:929 | trim | −$15.9M | −408,000 | $40.1M | $24.2M | 2,000,000 | 1,592,000 | |
INTUITIVE SURGICAL INC COM NEWposition key pos:17712 · issuer key iss:1213 | trim | −$10.6M | −9,030 | $34.6M | $24.0M | 61,073 | 52,043 | |
GRIFOLS S A SP ADR REP B NVTposition key sid:sec:prov:0e98b3abdccb3abb7f7b05b1196945d8 · issuer key cusip6:398438 | add | −$1.9M | +220,000 | $25.9M | $24.0M | 2,768,000 | 2,988,000 | |
PENN ENTERTAINMENT INC COMposition key pos:17549 · issuer key iss:1693 | trim | −$21.9M | −1,518,000 | $45.7M | $23.7M | 3,096,000 | 1,578,000 | |
SOLID BIOSCIENCES INC COM NEWposition key pos:12592 · issuer key iss:2004 | add | +$8.3M | +588,000 | $14.7M | $23.0M | 2,612,000 | 3,200,000 | |
GITLAB INC CLASS A COMposition key sid:sec:prov:431d99b61e91bc00d72171223c54fba0 · issuer key cusip6:37637K | add | −$10.0M | +169,739 | $32.2M | $22.3M | 858,925 | 1,028,664 | |
AUTOLUS THERAPEUTICS LTD SPON ADSposition key sid:sec:prov:0cba59ee844ea8b6e5b356f9157cdead · issuer key cusip6:05280R | trim | −$13.0M | −1,700,000 | $34.8M | $21.8M | 17,500,000 | 15,800,000 | |
SENTINELONE INC CL Aposition key pos:12386 · issuer key iss:1955 CALL | trim | −$26.7M | −1,550,000 | $48.0M | $21.3M | 3,200,000 | 1,650,000 | |
ANGIODYNAMICS INC COMposition key pos:14523 · issuer key iss:203 | add | −$577K | +169,000 | $21.8M | $21.3M | 1,700,000 | 1,869,000 | |
ARVINAS INC COMposition key pos:12209 · issuer key iss:250 | add | −$381K | +178,000 | $21.3M | $21.0M | 1,800,000 | 1,978,000 | |
TAIWAN SEMICONDUCTOR MANUFAC SPONSORED ADSposition key pos:18380 · issuer key iss:2080 | add | +$5.5M | +11,254 | $15.2M | $20.7M | 50,000 | 61,254 | |
ALTO NEUROSCIENCE INC COM SHSposition key sid:sec:prov:d8f1dce881f876173d775baaae476159 · issuer key cusip6:02157Q | trim | −$6.8M | −624,000 | $27.3M | $20.5M | 1,536,000 | 912,000 | |
ENERGIZER HLDGS INC COMposition key sid:sec:prov:7238aa41158ebd8084353f3976d45d0e · issuer key cusip6:29272W | add | −$902K | +164,000 | $20.6M | $19.7M | 1,036,000 | 1,200,000 | |
FIVE9 INC COMposition key pos:10974 · issuer key iss:929 CALL | trim | −$17.1M | −550,000 | $36.1M | $19.0M | 1,800,000 | 1,250,000 | |
META PLATFORMS INC CL Aposition key pos:12241 · issuer key iss:891 | new | +$18.6M | +32,594 | $0 | $18.6M | — | 32,594 | |
4D MOLECULAR THERAPEUTICS IN COMposition key sid:sec:prov:adc22e9a1524ab89aa68e69a21eb8d93 · issuer key cusip6:35104E | add | +$4.1M | +64,000 | $14.5M | $18.6M | 1,936,000 | 2,000,000 | |
MICROSOFT CORP COMposition key pos:12680 · issuer key iss:1473 | trim | −$39.1M | −69,477 | $57.2M | $18.1M | 118,337 | 48,860 | |
EDWARDS LIFESCIENCES CORP COMposition key pos:17342 · issuer key iss:799 | trim | −$5.7M | −52,643 | $23.7M | $18.0M | 277,478 | 224,835 | |
WYNN RESORTS LTD COMposition key pos:13896 · issuer key iss:2359 | trim | −$3.6M | −2,645 | $21.2M | $17.6M | 176,190 | 173,545 | |
MACROGENICS INC COMposition key sid:sec:prov:2cf06ac89e78fe7c69baaccedd98a9c7 · issuer key cusip6:556099 | trim | +$7.2M | −312,000 | $10.2M | $17.4M | 6,324,000 | 6,012,000 | |
SCHOLAR ROCK HLDG CORP COMposition key pos:18628 · issuer key iss:1936 | add | +$7.8M | +136,959 | $8.8M | $16.6M | 200,000 | 336,959 | |
BICYCLE THERAPEUTICS PLC SPONSORED ADSposition key pos:17645 · issuer key iss:368 | add | −$7.1M | +162,000 | $22.9M | $15.8M | 3,236,000 | 3,398,000 | |
CENTRAL GARDEN & PET CO CL A NON-VTGposition key sid:sec:prov:d26d9a2073ff14f944fae9a38cd0684a · issuer key cusip6:153527 | new | +$15.5M | +478,000 | $0 | $15.5M | — | 478,000 | |
LENNAR CORP CL Aposition key pos:16818 · issuer key iss:1340 | add | −$181K | +25,718 | $15.6M | $15.4M | 151,295 | 177,013 | |
TOAST INC CL Aposition key pos:11997 · issuer key iss:2141 | add | +$7.2M | +349,718 | $8.1M | $15.3M | 227,753 | 577,471 | |
SANOFI SA SPONSORED ADRposition key pos:11566 · issuer key iss:1928 | trim | −$18.3M | −376,000 | $32.8M | $14.5M | 676,000 | 300,000 | |
BILL HOLDINGS INC COMposition key pos:15704 · issuer key iss:370 | add | −$443K | +103,519 | $14.8M | $14.4M | 271,389 | 374,908 | |
UIPATH INC CL Aposition key pos:12507 · issuer key iss:2190 | trim | −$10.7M | −239,897 | $25.0M | $14.3M | 1,524,617 | 1,284,720 | |
PENN ENTERTAINMENT INC COMposition key pos:17549 · issuer key iss:1693 CALL | new | +$13.5M | +900,000 | $0 | $13.5M | — | 900,000 | |
VOYAGER THERAPEUTICS INC COMposition key sid:sec:prov:049c2d4f45ba193716199e4b705e328c · issuer key cusip6:92915B | trim | −$2.2M | −500,000 | $15.7M | $13.5M | 4,000,000 | 3,500,000 | |
CYTOKINETICS INC COM NEWposition key pos:13331 · issuer key iss:700 PUT | new | +$13.2M | +200,000 | $0 | $13.2M | — | 200,000 | |
GSK PLC SPONSORED ADRposition key pos:16974 · issuer key iss:1013 | trim | −$36.0M | −764,000 | $49.0M | $13.0M | 1,000,000 | 236,000 | |
TERADYNE INC COMposition key pos:16218 · issuer key iss:2113 | add | +$7.5M | +15,630 | $5.5M | $13.0M | 28,302 | 43,932 | |
CROCS INC COMposition key pos:15511 · issuer key iss:683 | trim | −$3.4M | −35,757 | $16.3M | $12.8M | 190,350 | 154,593 | |
NIKE INC CL Bposition key pos:14767 · issuer key iss:1571 | trim | −$12.7M | −158,169 | $25.1M | $12.5M | 394,709 | 236,540 | |
BRISTOL-MYERS SQUIBB CO COMposition key pos:15894 · issuer key iss:435 | trim | −$7.7M | −167,442 | $20.1M | $12.4M | 372,466 | 205,024 | |
VERA THERAPEUTICS INC CL Aposition key sid:sec:prov:c6f0567aff349dfe2dab4a6ee5ba8988 · issuer key cusip6:92337R | trim | −$21.1M | −355,632 | $33.1M | $12.0M | 653,796 | 298,164 | |
BRIDGEBIO ONCOLOGY THERAPEUT COM NEWposition key pos:12931 · issuer key iss:426 | add | −$634K | +328,000 | $12.5M | $11.9M | 1,000,000 | 1,328,000 | |
CAPRI HOLDINGS LIMITED SHSposition key pos:15998 · issuer key iss:2469 | new | +$11.6M | +658,000 | $0 | $11.6M | — | 658,000 | |
NEBIUS GROUP N.V. SHS CLASS Aposition key pos:12696 · issuer key iss:2711 | trim | −$11.2M | −159,421 | $22.4M | $11.2M | 267,421 | 108,000 | |
XERIS BIOPHARMA HOLDINGS INC COMposition key pos:13549 · issuer key iss:2367 | new | +$11.1M | +1,909,838 | $0 | $11.1M | — | 1,909,838 | |
ESPERION THERAPEUTICS INC NE COMposition key pos:16937 · issuer key iss:852 | new | +$10.8M | +3,930,125 | $0 | $10.8M | — | 3,930,125 | |
IQVIA HLDGS INC COMposition key pos:17397 · issuer key iss:1223 | new | +$10.4M | +60,884 | $0 | $10.4M | — | 60,884 | |
ROSS STORES INC COMposition key pos:11508 · issuer key iss:1870 | trim | −$9.6M | −63,126 | $20.0M | $10.4M | 111,034 | 47,908 | |
NVIDIA CORPORATION COMposition key pos:16535 · issuer key iss:1593 | trim | −$1.6M | −4,686 | $11.9M | $10.3M | 63,955 | 59,269 | |
SANGAMO THERAPEUTICS INC COMposition key sid:sec:prov:670e7a62cbda3ccc5db947ec9ee5e2d7 · issuer key cusip6:800677 | new | +$10.0M | +40,400,067 | $0 | $10.0M | — | 40,400,067 | |
INTEL CORP COMposition key pos:19062 · issuer key iss:1193 | add | +$5.3M | +101,059 | $4.5M | $9.9M | 122,936 | 223,995 | |
APPLOVIN CORP COM CL Aposition key pos:16993 · issuer key iss:228 | add | −$5.3M | +2,160 | $15.0M | $9.7M | 22,262 | 24,422 | |
WORKDAY INC CL Aposition key pos:18522 · issuer key iss:2354 | trim | −$10.6M | −19,898 | $20.2M | $9.6M | 93,893 | 73,995 | |
REDDIT INC CL Aposition key pos:11728 · issuer key iss:1821 | trim | −$8.2M | −6,600 | $17.6M | $9.4M | 76,600 | 70,000 | |
NEUROPACE INC COMposition key sid:sec:prov:3402bbe7c4ba34aeef0c97588550f290 · issuer key cusip6:641288 | trim | −$3.1M | −100,000 | $12.2M | $9.1M | 792,000 | 692,000 | |
ZURA BIO LTD CLASS A ORD SHSposition key sid:sec:prov:37f8d7b8f8c97e91dcf78ef12d0dd5a9 · issuer key cusip6:G9TY5A | trim | +$792K | −53,000 | $8.2M | $9.0M | 1,560,000 | 1,507,000 | |
PEGASYSTEMS INC COMposition key pos:16745 · issuer key iss:1690 | add | +$1.1M | +78,435 | $7.9M | $9.0M | 131,994 | 210,429 | |
GENERAC HLDGS INC COMposition key pos:13771 · issuer key iss:995 | new | +$8.8M | +44,902 | $0 | $8.8M | — | 44,902 | |
GE HEALTHCARE TECHNOLOGIES I COMMON STOCKposition key pos:17257 · issuer key iss:981 | trim | −$56.5M | −673,711 | $65.0M | $8.4M | 792,000 | 118,289 | |
MICRON TECHNOLOGY INC COMposition key pos:16109 · issuer key iss:1476 | new | +$7.9M | +23,293 | $0 | $7.9M | — | 23,293 |
80 more changes below.
1–100 of 452 changes
Mark-to-market only (no share change) · 17
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
AXOGEN INC COMposition key sid:sec:prov:fd61a14f8c16900d70648b14bc187bfb · issuer key cusip6:05463X | no change | +$374K | 0 | $30.6M | $31.0M | 936,000 | 936,000 | |
TREACE MED CONCEPTS INC COMposition key sid:sec:prov:c08a16c0af7981adc90fd977ca92e202 · issuer key cusip6:89455T | no change | −$7.1M | 0 | $15.6M | $8.5M | 6,364,000 | 6,364,000 | |
KYNTRA BIO INC COM NEWposition key sid:sec:prov:6ea21d63f42e751642c219cdf4c44eee · issuer key cusip6:31572Q | no change | −$800K | 0 | $3.5M | $2.7M | 400,000 | 400,000 | |
PURSUIT ATTRACTIONS AND HOSP COMposition key sid:sec:prov:2f108e284193cdde1e047a105f455099 · issuer key cusip6:92552R | no change | +$140K | 0 | $1.6M | $1.7M | 47,500 | 47,500 | |
MARIS TECH LTD *W EXP 02/04/202position key sid:sec:prov:ad5917478a4dafa1e60c5d41ce7ed355 · issuer key cusip6:M68057 | no change | +$39.1K | 0 | $151K | $190K | 1,261,058 | 1,261,058 | |
BIOVIE INC *W EXP 08/08/203position key sid:sec:prov:0fcb62a90d06d9c6fb59e4e7c4720e95 · issuer key cusip6:09074F | no change | +$26.5K | 0 | $129K | $155K | 500,000 | 500,000 | |
HEARTBEAM INC *W EXP 10/31/202position key sid:sec:prov:45a88905bf6b015b2c4bec16254bc985 · issuer key cusip6:42238H | no change | −$100.0K | 0 | $160K | $60.1K | 500,000 | 500,000 | |
MEDICUS PHARMA LTD *W EXP 11/15/202position key sid:sec:prov:dc991f580e23059100e0575b143cb1a9 · issuer key cusip6:58471K | no change | +$9.1K | 0 | $48.5K | $57.6K | 60,600 | 60,600 | |
NEXGEL INC *W EXP 12/27/202position key sid:sec:prov:bcc0a1a3fc7e67edbf27fd39d5bbecc3 · issuer key cusip6:65344E | no change | −$96.4K | 0 | $129K | $32.9K | 550,000 | 550,000 | |
LOCAFY LIMITED *W EXP 03/29/202position key sid:sec:prov:32efbe47543ba5bc495e7517969f678b · issuer key cusip6:Q56120 | no change | +$4.7K | 0 | $26.8K | $31.5K | 12,121 | 12,121 | |
ONFOLIO HOLDINGS INC *W EXP 01/02/202position key sid:sec:prov:6bb2198a93ff3056435b88f9771811f5 · issuer key cusip6:68277K | no change | −$9.5K | 0 | $34.0K | $24.5K | 400,000 | 400,000 | |
STRAN & COMPANY INC *W EXP 99/99/999position key sid:sec:prov:a725fdbdd13bddb0eb49815a7b7963c8 · issuer key cusip6:86260J | no change | −$763 | 0 | $21.8K | $21.0K | 545,000 | 545,000 | |
FGI INDUSTRIES LTD *W EXP 99/99/999position key sid:sec:prov:5ec1fa1ce02c2e96f77055e523182986 · issuer key cusip6:G3302D | no change | −$4.1K | 0 | $10.0K | $6.0K | 186,666 | 186,666 | |
PRESIDIO PPTY TR INC *W EXP 01/24/202position key sid:sec:prov:1a4aa59a6952de3e16f2b5c3887ad6f8 · issuer key cusip6:74102L | no change | −$2.0K | 0 | $6.0K | $4.0K | 200,000 | 200,000 | |
IVEDA SOLUTIONS INC *W EXP 04/01/202position key sid:sec:prov:18d4df07d1f7580af8d465c7199fb67e · issuer key cusip6:46583A | no change | −$1.5K | 0 | $2.2K | $745 | 18,125 | 18,125 | |
PASITHEA THERAPEUTICS CORP *W EXP 08/12/202position key sid:sec:prov:6e8bc748698a3016bf2d4f2529e8ae67 · issuer key cusip6:70261F | no change | −$140 | 0 | $705 | $565 | 50,000 | 50,000 | |
TENON MEDICAL INC *W EXP 06/16/202position key sid:sec:prov:d28b9d4819261519edf3475433d30502 · issuer key cusip6:88066N | no change | −$56 | 0 | $234 | $178 | 22,250 | 22,250 |
Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Changes derive from the aggregate's top-25 slices and keyable positions only; unkeyable holdings are counted in the registry, not differenced. methodology §13F ↗
Book shape
2026-03-31 · concentration · vs tracked median · tick = median- Top-25 concentration
- 69.7%below median 80.0%
- Concentration index
- 886 bpsabove median 446 bps
- Positions with value
- 267 / 267median book 97.5 positions
Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.
null-value positions: 0holdings whose <value> did not parse — retained and counted, never zero-filled · top-N share ·§: 69.7% · HHI (bps) ·§: 886integer Herfindahl–Hirschman index in basis points over disclosed position values · QoQ moves: 469
Filing history
AVAILABLE QUARTERS| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
PLANNED sector rotation · Congress overlap · signals for this filer
Complete source filings on SEC EDGAR
The complete filing on EDGAR.
The position list above is served from the published Public Filings build — every position this filer reported for the selected quarter, as it reported it. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Serving this list is M2-CONTRACT §3, amended 2026-08-02; §3.1 keeps live EDGAR for filings newer than this build.
Open ARMISTICE CAPITAL, LLC's 13F filings on SEC EDGAR ↗Notes on this data
Share changes
Compare consecutive quarters
Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.
Coverage
A snapshot, not current holdings
Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.
ViewPrior quarter not yet availableThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Reported positions — 2026-03-31
1–100 of 252 issuers · $5.6B disclosed value over 267 rows · 0 undisclosed-value rowsEvery row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| KindClassification is not joined into this reported-position view. Use the changed-positions view to compare the two published quarters. | TickerThis list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | Issuera position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | WeightShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | Valuevalue undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Position changeShare change is available in the separate comparison view; it is not joined into this position list. | Wt | CongressThe congressional transaction join is unavailable in this build. | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | SPYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | STATE STR SPDR S&P 500 ETF T STATE STR SPDR S&P 500 ETF T · TR UNIT · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $1.4B | 2,100,000 | — | 24.3% | — | |||||||||||||
| — | — | ISHARES TR ISHARES TR · RUSSELL 2000 ETF · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $868M | 3,500,000 | — | 15.4% | — | |||||||||||||
| — | — | AGIOS PHARMACEUTICALS INC | $200M | 5,916,000 | — | 3.6% | — | |||||||||||||
| — | CYTKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CYTOKINETICS INC3 positions · 4 reported rows
| $176M | 2,664,538 | — | 3.1% | — | |||||||||||||
| — | PTCTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PTC THERAPEUTICS INC | $168M | 2,464,449 | — | 3.0% | — | |||||||||||||
| — | TVTXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $146M | 4,897,417 | — | 2.6% | — | |||||||||||||
| — | MDGLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MADRIGAL PHARMACEUTICALS INC | $139M | 264,583 | — | 2.5% | — | |||||||||||||
| — | — | IMMUNOVANT INC2 positions · 4 reported rows
| $136M | 5,464,916 | — | 2.4% | — | |||||||||||||
| — | — | SUPERNUS PHARMACEUTICALS SUPERNUS PHARMACEUTICALS · COM CUSIP 868459108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $98.0M | 1,895,347 | — | 1.7% | — | |||||||||||||
| — | NBIXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $95.4M | 724,000 | — | 1.7% | — | |||||||||||||
| — | FRPTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FRESHPET INC FRESHPET INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $64.5M | 1,093,307 | — | 1.1% | — | |||||||||||||
| — | INCYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INCYTE CORP INCYTE CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $61.8M | 656,817 | — | 1.1% | — | |||||||||||||
| — | DYNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DYNE THERAPEUTICS INC DYNE THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $57.6M | 3,175,110 | — | 1.0% | — | |||||||||||||
| — | AMZNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AMAZON COM INC AMAZON COM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $54.6M | 262,137 | — | 1.0% | — | |||||||||||||
| — | IRWDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $52.7M | 15,028,000 | — | 0.9% | — | |||||||||||||
| — | Sverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SENTINELONE INC | $45.7M | 3,547,849 | — | 0.8% | — | |||||||||||||
| — | HRMYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HARMONY BIOSCIENCES HLDGS IN HARMONY BIOSCIENCES HLDGS IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $45.5M | 1,624,000 | — | 0.8% | — | |||||||||||||
| — | TMOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | THERMO FISHER SCIENTIFIC INC THERMO FISHER SCIENTIFIC INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $45.0M | 91,491 | — | 0.8% | — | |||||||||||||
| — | FIVNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FIVE9 INC | $43.1M | 2,842,000 | — | 0.8% | — | |||||||||||||
| — | — | NEKTAR THERAPEUTICS NEKTAR THERAPEUTICS · COM NEW CUSIP 640268306 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $41.6M | 578,000 | — | 0.7% | — | |||||||||||||
| — | UNHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UNITEDHEALTH GROUP INC UNITEDHEALTH GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $40.0M | 148,000 | — | 0.7% | — | |||||||||||||
| — | UBERverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UBER TECHNOLOGIES INC UBER TECHNOLOGIES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.3M | 518,760 | — | 0.7% | — | |||||||||||||
| — | PENNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PENN ENTERTAINMENT INC | $37.2M | 2,478,000 | — | 0.7% | — | |||||||||||||
| — | IMCRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IMMUNOCORE HLDGS PLC IMMUNOCORE HLDGS PLC · ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $35.8M | 1,188,000 | — | 0.6% | — | |||||||||||||
| — | XRAYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DENTSPLY SIRONA INC DENTSPLY SIRONA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $34.8M | 3,000,000 | — | 0.6% | — | |||||||||||||
| — | — | RIGEL PHARMACEUTICALS INC RIGEL PHARMACEUTICALS INC · COM CUSIP 766559702 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $34.6M | 1,280,000 | — | 0.6% | — | |||||||||||||
| — | IRONverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DISC MEDICINE INC DISC MEDICINE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $34.3M | 536,000 | — | 0.6% | — | |||||||||||||
| — | GOOGLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ALPHABET INC ALPHABET INC · CAP STK CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $34.1M | 118,514 | — | 0.6% | — | |||||||||||||
| — | — | MINERALYS THERAPEUTICS INC MINERALYS THERAPEUTICS INC · COM CUSIP 603170101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.9M | 1,176,000 | — | 0.6% | — | |||||||||||||
| — | HUBSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HUBSPOT INC HUBSPOT INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.4M | 128,583 | — | 0.6% | — | |||||||||||||
| — | — | AXOGEN INC AXOGEN INC · COM CUSIP 05463X106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.0M | 936,000 | — | 0.6% | — | |||||||||||||
| — | — | ORTHOFIX MED INC ORTHOFIX MED INC · COM CUSIP 68752M108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $31.0M | 2,700,000 | — | 0.6% | — | |||||||||||||
| — | — | KURA ONCOLOGY INC KURA ONCOLOGY INC · COM CUSIP 50127T109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $30.4M | 3,736,000 | — | 0.5% | — | |||||||||||||
| — | AVNSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AVANOS MED INC AVANOS MED INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $28.0M | 2,000,000 | — | 0.5% | — | |||||||||||||
| — | REGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REGENERON PHARMACEUTICALS REGENERON PHARMACEUTICALS · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.9M | 36,126 | — | 0.5% | — | |||||||||||||
| — | ALGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ALIGN TECHNOLOGY INC ALIGN TECHNOLOGY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.1M | 157,959 | — | 0.5% | — | |||||||||||||
| — | MDBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MONGODB INC MONGODB INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $26.3M | 107,296 | — | 0.5% | — | |||||||||||||
| — | BABAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ALIBABA GROUP HLDG LTD ALIBABA GROUP HLDG LTD · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.6M | 204,000 | — | 0.5% | — | |||||||||||||
| — | MDLNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MEDLINE INC MEDLINE INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $25.1M | 564,857 | — | 0.4% | — | |||||||||||||
| — | — | KALVISTA PHARMACEUTICALS INC KALVISTA PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.9M | 1,236,000 | — | 0.4% | — | |||||||||||||
| — | DDOGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DATADOG INC DATADOG INC · CL A COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.6M | 208,564 | — | 0.4% | — | |||||||||||||
| — | HUMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HUMANA INC HUMANA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.5M | 141,279 | — | 0.4% | — | |||||||||||||
| — | — | VERASTEM INC VERASTEM INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.3M | 4,592,000 | — | 0.4% | — | |||||||||||||
| — | ISRGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.0M | 52,043 | — | 0.4% | — | |||||||||||||
| — | — | GRIFOLS S A GRIFOLS S A · SP ADR REP B NVT CUSIP 398438408 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.0M | 2,988,000 | — | 0.4% | — | |||||||||||||
| — | SLDBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SOLID BIOSCIENCES INC SOLID BIOSCIENCES INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.0M | 3,200,000 | — | 0.4% | — | |||||||||||||
| — | — | GITLAB INC GITLAB INC · CLASS A COM CUSIP 37637K108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $22.3M | 1,028,664 | — | 0.4% | — | |||||||||||||
| — | — | AUTOLUS THERAPEUTICS LTD AUTOLUS THERAPEUTICS LTD · SPON ADS CUSIP 05280R100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $21.8M | 15,800,000 | — | 0.4% | — | |||||||||||||
| — | ANGOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ANGIODYNAMICS INC ANGIODYNAMICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $21.3M | 1,869,000 | — | 0.4% | — | |||||||||||||
| — | ARVNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARVINAS INC ARVINAS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $21.0M | 1,978,000 | — | 0.4% | — | |||||||||||||
| — | TSMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TAIWAN SEMICONDUCTOR MANUFAC TAIWAN SEMICONDUCTOR MANUFAC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $20.7M | 61,254 | — | 0.4% | — | |||||||||||||
| — | — | ALTO NEUROSCIENCE INC ALTO NEUROSCIENCE INC · COM SHS CUSIP 02157Q109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $20.5M | 912,000 | — | 0.4% | — | |||||||||||||
| — | — | ENERGIZER HLDGS INC ENERGIZER HLDGS INC · COM CUSIP 29272W109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $19.7M | 1,200,000 | — | 0.4% | — | |||||||||||||
| — | METAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | META PLATFORMS INC META PLATFORMS INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $18.6M | 32,594 | — | 0.3% | — | |||||||||||||
| — | — | 4D MOLECULAR THERAPEUTICS IN 4D MOLECULAR THERAPEUTICS IN · COM CUSIP 35104E100 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $18.6M | 2,000,000 | — | 0.3% | — | |||||||||||||
| — | MSFTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MICROSOFT CORP MICROSOFT CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $18.1M | 48,860 | — | 0.3% | — | |||||||||||||
| — | EWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EDWARDS LIFESCIENCES CORP EDWARDS LIFESCIENCES CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $18.0M | 224,835 | — | 0.3% | — | |||||||||||||
| — | WYNNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WYNN RESORTS LTD WYNN RESORTS LTD · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $17.6M | 173,545 | — | 0.3% | — | |||||||||||||
| — | — | MACROGENICS INC MACROGENICS INC · COM CUSIP 556099109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $17.4M | 6,012,000 | — | 0.3% | — | |||||||||||||
| — | SRRKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SCHOLAR ROCK HLDG CORP SCHOLAR ROCK HLDG CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $16.6M | 336,959 | — | 0.3% | — | |||||||||||||
| — | BCYCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BICYCLE THERAPEUTICS PLC BICYCLE THERAPEUTICS PLC · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.8M | 3,398,000 | — | 0.3% | — | |||||||||||||
| — | — | CENTRAL GARDEN & PET CO CENTRAL GARDEN & PET CO · CL A NON-VTG CUSIP 153527205 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.5M | 478,000 | — | 0.3% | — | |||||||||||||
| — | LENverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LENNAR CORP LENNAR CORP · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.4M | 177,013 | — | 0.3% | — | |||||||||||||
| — | TOSTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TOAST INC TOAST INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.3M | 577,471 | — | 0.3% | — | |||||||||||||
| — | SNYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SANOFI SA SANOFI SA · SPONSORED ADR CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.5M | 300,000 | — | 0.3% | — | |||||||||||||
| — | BILLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BILL HOLDINGS INC BILL HOLDINGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.4M | 374,908 | — | 0.3% | — | |||||||||||||
| — | PATHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UIPATH INC UIPATH INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $14.3M | 1,284,720 | — | 0.3% | — | |||||||||||||
| — | — | VOYAGER THERAPEUTICS INC VOYAGER THERAPEUTICS INC · COM CUSIP 92915B106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $13.5M | 3,500,000 | — | 0.2% | — | |||||||||||||
| — | GSKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GSK PLC GSK PLC · SPONSORED ADR CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $13.0M | 236,000 | — | 0.2% | — | |||||||||||||
| — | TERverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TERADYNE INC TERADYNE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $13.0M | 43,932 | — | 0.2% | — | |||||||||||||
| — | CROXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CROCS INC CROCS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.8M | 154,593 | — | 0.2% | — | |||||||||||||
| — | NKEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NIKE INC NIKE INC · CL B CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.5M | 236,540 | — | 0.2% | — | |||||||||||||
| — | BMYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BRISTOL-MYERS SQUIBB CO BRISTOL-MYERS SQUIBB CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.4M | 205,024 | — | 0.2% | — | |||||||||||||
| — | — | VERA THERAPEUTICS INC VERA THERAPEUTICS INC · CL A CUSIP 92337R101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.0M | 298,164 | — | 0.2% | — | |||||||||||||
| — | BBOTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BRIDGEBIO ONCOLOGY THERAPEUT BRIDGEBIO ONCOLOGY THERAPEUT · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.9M | 1,328,000 | — | 0.2% | — | |||||||||||||
| — | CPRIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CAPRI HOLDINGS LIMITED CAPRI HOLDINGS LIMITED · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.6M | 658,000 | — | 0.2% | — | |||||||||||||
| — | NBISverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NEBIUS GROUP N.V. NEBIUS GROUP N.V. · SHS CLASS A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.2M | 108,000 | — | 0.2% | — | |||||||||||||
| — | XERSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | XERIS BIOPHARMA HOLDINGS INC XERIS BIOPHARMA HOLDINGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.1M | 1,909,838 | — | 0.2% | — | |||||||||||||
| — | ESPRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ESPERION THERAPEUTICS INC NE ESPERION THERAPEUTICS INC NE · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.8M | 3,930,125 | — | 0.2% | — | |||||||||||||
| — | IQVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | IQVIA HLDGS INC IQVIA HLDGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.4M | 60,884 | — | 0.2% | — | |||||||||||||
| — | ROSTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROSS STORES INC ROSS STORES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.4M | 47,908 | — | 0.2% | — | |||||||||||||
| — | NVDAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NVIDIA CORPORATION NVIDIA CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.3M | 59,269 | — | 0.2% | — | |||||||||||||
| — | — | SANGAMO THERAPEUTICS INC SANGAMO THERAPEUTICS INC · COM CUSIP 800677106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $10.0M | 40,400,067 | — | 0.2% | — | |||||||||||||
| — | INTCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTEL CORP INTEL CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.9M | 223,995 | — | 0.2% | — | |||||||||||||
| — | APPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | APPLOVIN CORP APPLOVIN CORP · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.7M | 24,422 | — | 0.2% | — | |||||||||||||
| — | WDAYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WORKDAY INC WORKDAY INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.6M | 73,995 | — | 0.2% | — | |||||||||||||
| — | RDDTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REDDIT INC REDDIT INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.4M | 70,000 | — | 0.2% | — | |||||||||||||
| — | — | NEUROPACE INC NEUROPACE INC · COM CUSIP 641288105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.1M | 692,000 | — | 0.2% | — | |||||||||||||
| — | — | ZURA BIO LTD ZURA BIO LTD · CLASS A ORD SHS CUSIP G9TY5A101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.0M | 1,507,000 | — | 0.2% | — | |||||||||||||
| — | PEGAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PEGASYSTEMS INC PEGASYSTEMS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.0M | 210,429 | — | 0.2% | — | |||||||||||||
| — | GNRCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GENERAC HLDGS INC GENERAC HLDGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.8M | 44,902 | — | 0.2% | — | |||||||||||||
| — | — | TREACE MED CONCEPTS INC TREACE MED CONCEPTS INC · COM CUSIP 89455T109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.5M | 6,364,000 | — | 0.2% | — | |||||||||||||
| — | GEHCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GE HEALTHCARE TECHNOLOGIES I GE HEALTHCARE TECHNOLOGIES I · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.4M | 118,289 | — | 0.1% | — | |||||||||||||
| — | MUverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MICRON TECHNOLOGY INC MICRON TECHNOLOGY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.9M | 23,293 | — | 0.1% | — | |||||||||||||
| — | — | TENAX THERAPEUTICS INC TENAX THERAPEUTICS INC · COM NEW CUSIP 88032L605 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.7M | 478,827 | — | 0.1% | — | |||||||||||||
| — | NUVBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NUVATION BIO INC NUVATION BIO INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.4M | 1,736,000 | — | 0.1% | — | |||||||||||||
| — | INGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INOGEN INC INOGEN INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.4M | 1,200,000 | — | 0.1% | — | |||||||||||||
| — | ORLYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | OREILLY AUTOMOTIVE INC OREILLY AUTOMOTIVE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.2M | 78,103 | — | 0.1% | — | |||||||||||||
| — | KYMRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KYMERA THERAPEUTICS INC KYMERA THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $7.0M | 83,876 | — | 0.1% | — | |||||||||||||
| — | — | DOGWOOD THERAPEUTICS INC DOGWOOD THERAPEUTICS INC · COM NEW CUSIP 92829J203 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.9M | 3,280,000 | — | 0.1% | — |
1–100 of 252 issuers · page 1 of 3
every row this filer reported for the quarter, as it reported it — cross-filer de-duplication is applied to issuer totals elsewhere and never deletes a row here
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.
Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).